Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

The field of endocrine oncology comprises a broad range of diseases, both malignant and benign. It includes tumors of hormone-secreting glands, such as the pituitary, thyroid, pancreatic and adrenal glands, along with neuroendocrine tumors. While some of these tumors are rare, together they affect a large number of patients every year. The field of endocrine oncology is continually evolving in a bid to diagnose disease early and develop therapies with high rates of success and low adverse events.

The Future Endocrinology & Metabolism is a peer-reviewed, open access journal that helps the clinician to keep up to date with best practice in this fast-moving field. The journal highlights significant advances in basic and translational research, and places them in context for future therapy.

The journal presents the latest research findings in diagnosis and management of endocrine cancer, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. The journal welcomes the unsolicited submission of article proposals and original research manuscripts.

Coverage includes:

  • All malignancies arising from cells of the endocrine system
  • Neuroendocrine, carcinoid, thyroid, parathyroid and islet cell tumors
  • Tumors of the gonads and adrenal and pituitary glands
  • Biological, systemic and radiotherapies
  • Biomarkers and translational research
  • Clinical trials
  • Diagnosis and imaging
  • Epidemiology, risk and prevention
  • Evidence-based treatment guidelines
  • Pharmacoeconomics and outcomes research
  • Post-treatment management
  • Surgical approaches


Future Endocrinology & Metabolism provides an accessible and thorough overview of current and emerging diagnostic and treatment strategies for tumors arising from hormone-producing cells, in clear and concise article formats.

Read full aims and scope

Latest issues

List of issues